Research ArticleOriginal Article
Open Access

Synergistic efficacies of thymoquinone and standard antibiotics against multi-drug resistant isolates

Ayed A. Dera, Irfan Ahmad, Prasanna Rajagopalan, Mesfer Al Shahrani, Ahmed Saif, Mohammad Y. Alshahrani, Yasser Alraey, Ahmad M. Alamri, Sultan Alasmari, Mohammed Makkawi, Ali G. Alkhathami, Gaffar Zaman, Abdulrahim Hakami, Razan Alhefzi and Mohammad A. Alfhili
Saudi Medical Journal February 2021, 42 (2) 196-204; DOI: https://doi.org/10.15537/smj.2021.2.25706

References

  1. 1.↵
    1. Abdallah EM.
    Black seed (Nigella sativa) as antimicrobial drug: a mini-Review. Nov Appro Drug Des Dev 2017; 3: 555603.
    OpenUrl
  2. 2.↵
    1. Gold HS,
    2. Moellering RC.
    Antimicrobial-drug resistance. N Engl J Med 1996; 335: 1445-1453.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Bajera T,
    2. Silha D,
    3. Ventura K,
    4. Bajerov P.
    Composition and antimicrobial activity of the essential oil, distilled aromatic water and herbal infusion from Epilobium parviflorum Schreb. Ind Crops Prod 2017; 100: 95-105.
    OpenUrl
  4. 4.↵
    1. Sonam C,
    2. Sharma K,
    3. Guleria S.
    Antimicrobial activity of some essential oils - present status and future perspectives. Medicines (Basel) 2017: 4: 58.
    OpenUrl
  5. 5.↵
    1. Okeke IN,
    2. Laxminarayan R,
    3. Bhutta ZA,
    4. Duse A,
    5. Jenkins P,
    6. O’Brien T, et al.
    Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis 2005; 5: 481-493.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Neu HC.
    The crisis in antibiotic resistance. Science 1992; 257: 1064-1073.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Eman H.
    Antibacterial activity of thymoquinone and thymohydroquinone of Nigella sativa L. and their interaction with some antibiotics. Adv Biol Res 2009; 3: 148-152.
    OpenUrlCrossRef
  8. 8.↵
    1. Drago L,
    2. De Vecchi E,
    3. Nicola L.
    In vitro evaluation of antibiotics’ combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections. BMC Infect Dis 2007; 7: 111.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Hemaiswarya S,
    2. Kruthiventi AK,
    3. Doble M.
    Synergism between natural products and antibiotics against infectious diseases. Phytomedicine 2008; 15: 639-652.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Mouwakeh A,
    2. Telbisz A,
    3. Spengler G,
    4. Mohácsi-Farkas C,
    5. Kiskó G.
    Antibacterial and resistance modifying activities of Nigella sativa essential oil and its active compounds against Listeria monocytogenes. In Vivo 2018; 32: 737-743.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Kokoska L.
    Chemistry and biological activity of Nigella genus: the antimicrobial and anti-inflammatory effects of seed extracts, essential oils and compounds of six Nigella species. Germany: LAP LAMBERT Academic Publishing; 2011.
  12. 12.↵
    1. Randhawa MA,
    2. Al-Ghamdi MS.
    A review of the pharmacotherapeutic effects of Nigella sativa. Pak J Med Res. 2020; 41: 77-83.
    OpenUrl
  13. 13.
    1. Dera A,
    2. Rajagopalan P.
    Thymoquinone attenuates phosphorylation of AKT to inhibit kidney cancer cell proliferation. J Food Biochem 2019; 43: e12793.
    OpenUrl
  14. 14.
    1. Dera AA,
    2. Rajagopalan P,
    3. Alfhili MA,
    4. Ahmed I,
    5. Chandramoorthy HC.
    Thymoquinone attenuates oxidative stress of kidney mitochondria and exerts nephroprotective effects in oxonic acid-induced hyperuricemia rats. Biofactors 2019; 46: 292-300.
    OpenUrl
  15. 15.
    1. Dera A,
    2. Rajagopalan P,
    3. Ahmed I,
    4. Alfhili M,
    5. Alsughayyir J,
    6. Chandramoorthy HC.
    Thymoquinone attenuates IgE-mediated allergic response via pi3k-Akt-NFκB pathway and upregulation of the Nrf2-HO1 axis. J Food Biochem 2020; 44: e13216.
    OpenUrl
  16. 16.↵
    1. Dera AA,
    2. Rajagopalan P,
    3. Al Fayi M,
    4. Ahmed I,
    5. Chandramoorthy HC.
    Indirubin-3-monoxime and thymoquinone exhibit synergistic efficacy as therapeutic combination in in-vitro and in-vivo models of lung cancer. Arch. Pharm Res 2020; 43: 655-665.
    OpenUrl
  17. 17.↵
    1. Asaduzzaman K,
    2. Tania M,
    3. Shangyi FU,
    4. Junjiang FU.
    (2017) Thymoquinone, as an anticancer molecule: from basic research to clinical investigation. Oncotarget 2017; 8: 51907-51919.
    OpenUrl
  18. 18.
    1. Bakathir HA,
    2. Abbas NA.
    Detection of the Antibacterial Effect of Nigella Sativa Ground Seeds with Water. Afr J Tradit Complement Altern Med 2011; 8: 159-164.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Randhawa MA,
    2. Alenazy AK,
    3. Alrowaili MG,
    4. Basha J.
    An active principle of Nigella sativa L., thymoquinone, showing significant antimicrobial activity against anaerobic bacteria. J Intercult Ethnopharmacol 2017; 6: 97-101.
    OpenUrl
  20. 20.↵
    1. El-Fatatry HM.
    Isolation and structure assignment of an anti-microbial principle from the volatile oil of Nigella sativa L seeds. Pharmazie 1975; 30: 109-111.
    OpenUrlPubMedWeb of Science
  21. 21.↵
    1. Hanafi MS,
    2. Hatem ME.
    Studies on the anti-microbial activity of the Nigella sativa seed (Black Cumin). J Ethnopharmacol 1991; 34: 275-278.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Morsi NM.
    Antimicrobial effect of crude extracts of Nigella sativa on multiple antibiotic resistant bacteria. Acta Microbiologica Polonica 2000; 49: 63-74.
    OpenUrlPubMed
  23. 23.↵
    1. Goyal SN,
    2. Prajapati CP,
    3. Gore PR,
    4. Patil CR,
    5. Mahajan UB,
    6. Sharma C.
    Therapeutic potential and pharmaceutical development of thymoquinone: a multitargeted molecule of natural origin. Front Pharmacol 2017; 8: 656.
    OpenUrl
  24. 24.↵
    1. Saquib SA,
    2. Al Qahtani NA,
    3. Ahmad I,
    4. Kader MA,
    5. Al Shahrani SS,
    6. Asiri EA.
    Evaluation and comparison of antibacterial efficacy of herbal extracts in combination with antibiotics on periodontal pathobionts: an in vitro microbiological study. Antibiotics 2019; 8: 89.
    OpenUrl
  25. 25.↵
    1. Nussdorfer P,
    2. Cilenšek I,
    3. Zorn B,
    4. Petrovic D.
    Adapted methods for scanning electron microscopy (SEM) in assessment of human sperm morphology. Bosn J Basic Med Sci 2018; 18: 43-48.
    OpenUrl
  26. 26.↵
    1. Eid RA,
    2. Alkhateeb MA,
    3. Al-Shraim M,
    4. Eleawa SM,
    5. Shatoor AS,
    6. El-Kott AF, et al.
    Ghrelin prevents cardiac cell apoptosis during cardiac remodelling post experimentally induced myocardial infarction in rats via activation of Raf-MEK1/2-ERK1/2 signalling. Arch Physiol Biochem 2019 125: 93–103.
  27. 27.↵
    1. Forouzanfar F,
    2. Fazly Bazzaz BS,
    3. Hosseinzadeh H.
    Black cumin (Nigella sativa) and its constituent (thymoquinone): a review on antimicrobial effects. Iran J Basic Med Sci 2014; 17: 929-938.
    OpenUrlPubMed
  28. 28.↵
    1. Raut JS,
    2. Shinde RB,
    3. Chauhan, NM,
    4. Karuppayil SM.
    Terpenoids of plant origin inhibit morphogenesis, adhesion, and biofilm formation by Candida albicans. Biofouling 2013; 29: 87-96.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Jin Y,
    2. Samaranayake LP,
    3. Samaranayake Y,
    4. Yip HK.
    Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars. Arch Oral 2004; 49: 789-798.
    OpenUrl
  30. 30.↵
    1. Abidi SH,
    2. Ahmed K,
    3. Sherwani SK,
    4. Kazmi SU.
    Synergy between antibiotics and natural agents results in increased antimicrobial activity against Staphylococcus epidermidis. J Infect Dev Countr 2015; 9: 925-929.
    OpenUrl
  31. 31.
    1. Dodou HV,
    2. de Morais Batista AH,
    3. Sales GWP,
    4. de Medeiros SC,
    5. Rodrigues ML,
    6. Nogueira PCN, et al.
    Violacein antimicrobial activity on Staphylococcus epidermidis and synergistic effect on commercially available antibiotics. J Appl Microbiol 2017; 123: 853-860.
    OpenUrl
  32. 32.↵
    1. Kiari FZ,
    2. Meddah B,
    3. Meddah AT.
    (In vitro study on the activity of essential oil and methanolic extract from Algerian Nigella sativa L. Seeds on the growth kinetics of micro-organisms isolated from the buccal cavities of periodontal patients. Saudi Dent J 2018; 30: 312-323.
    OpenUrl
  33. 33.↵
    1. Piddock LJV.
    Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 2006; 19: 382-382.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    1. Johana R,
    2. Pavel N,
    3. Urban J,
    4. Kokoska L.
    Determination of anti-staphylococcal activity of thymoquinone in combinations with antibiotics by checkerboard method using EVA capmat as a vapor barrier. Arab J Chem 2017; 10: 566-572.
    OpenUrl
  35. 35.↵
    1. Ogawa W,
    2. Li DW,
    3. Ping YU,
    4. Begum A,
    5. Mizushima T,
    6. Kuroda T.
    Multidrug resistance in Klebsiella pneumoniae MGH78578 and cloning of genes responsible for the resistance. Biol Pharm Bull 2005; 28: 1505-1508.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Salman MT,
    2. Khan RA,
    3. Shukla J.
    Antimicrobial activity of Nigella sativa Linn. seed oil against multi-drug resistant bacteria from clinical isolates. Nat Prod Radiance 2008; 7: 10-14.
    OpenUrl
  37. 37.↵
    1. Mandell G,
    2. Douglas J.,
    3. Bennett R.
    (1995) Principles and practices of infectious diseases, 4th ed. Edinburgh (UK): Churchill Livingstone; 1995. p. 80-112.
  38. 38.↵
    1. Handzlik J,
    2. Matys A,
    3. Kieć-Kononowicz K.
    Recent advances in multi-drug resistance (MDR) efflux pump inhibitors of Gram-positive bacteria S. aureus. Antibiotics (Basel) 2013; 2: 28-45.
    OpenUrl
  39. 39.↵
    1. Kouidhi B.,
    2. Zmantar T.,
    3. Jrah H.,
    4. Souiden Y.,
    5. Chaieb K.,
    6. Mahdouani K.
    Antibacterial and resistance modifying activities of thymoquinone against oral pathogens. Ann Clin Microbiol Antimicrob 2011; 10: 29.
    OpenUrlPubMed
  40. 40.↵
    1. Macheboeuf P,
    2. Contreras-Martel C,
    3. Job V,
    4. Dideberg O,
    5. Dessen A.
    Penicillin binding proteins: key players in bacterial cell cycle and drug resistance processes. FEMS Microbiol Rev 2006; 30: 673-691.
    OpenUrlCrossRefPubMedWeb of Science
  41. 41.↵
    1. An YH,
    2. Friedman RJ
    1. Steinberg D.
    Studying plaque biofilms on various dental surfaces. In: An YH, Friedman RJ, editors. Handbook of bacterial adhesion: principles, methods, and applications. Totowa (NJ): Humana Press; 2000. p. 353-370.
  42. 42.↵
    1. Cazzaniga G,
    2. Ottobelli M,
    3. Ionescu A,
    4. Garcia-Godoy F,
    5. Brambilla E.
    Surface properties of resin-based composite materials and biofilm formation: a review of the current literature. Am J Dent 2015; 28: 311-320.
    OpenUrl
  43. 43.↵
    1. Marsh PD.
    Dental plaque as a biofilm and a microbial community-implications for health and disease. BMC Oral Health. 2006; 6: S14.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords